Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 23andMe, Inc.
Numbers for genetic testing company’s October data breach much larger than previously reported; company might be trying to shield itself from class action complaints.
The numbers for the genetic testing company’s October data breach are much larger than previously reported, and now the company might be trying to shield itself from class action lawsuits.
After leading Paige to success with the FDA, Grady has turned his attention to the microbiome. He hopes his new company, Jona, will be able to provide detailed insights to doctors, their patients and pharmaceutical players.
The CEO of Korean bioventure Kanaph Therapeutics, Byoung Chul Lee, talks to Scrip about the difficulties such companies are going through amid generally weak investor sentiment, as well as the company's own financing and R&D plans.
- Laboratory Testing Services
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.